Quotient Limited to Participate in the 35th Annual J.P. Morgan Healthcare Conference
December 21 2016 - 8:00AM
Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics
company, today announced that the company's Chairman and Chief
Executive Officer, Paul Cowan, will present at the 35th annual J.P.
Morgan Healthcare Conference on Wednesday, January 11, 2017 at
10:00 a.m. Pacific Time at the Westin St. Francis on Union Square
in San Francisco, CA.
A webcast of the presentation will be available online from the
investor relations page of the Company's corporate website
at www.quotientbd.com. A webcast replay will be archived on
the website for approximately 90 days.
About Quotient Limited
Quotient is a commercial-stage diagnostics company committed to
reducing healthcare costs and improving patient care through the
provision of innovative tests within established markets. With an
initial focus on blood grouping and serological disease screening,
Quotient is developing its proprietary MosaiQ™ technology
platform to offer a breadth of tests that is unmatched by existing
commercially available transfusion diagnostic instrument platforms.
The company's operations are based in Edinburgh, Scotland; Eysins,
Switzerland and Newtown, Pennsylvania.
The Quotient logo and MosaiQ™ are registered trademarks or
trademarks of Quotient Limited and its subsidiaries in various
jurisdictions.
CONTACT: Paul Cowan, Chairman & Chief Executive Officer — CEO@quotientbd.com; 215-497-7006
Quotient (NASDAQ:QTNT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Quotient (NASDAQ:QTNT)
Historical Stock Chart
From Apr 2023 to Apr 2024